These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11246262)

  • 21. Diverse experience with the CardioSEAL and STARFlex septal occluders.
    Apostolopoulou SC; Laskari CV; Kiaffas M; Papagiannis J; Rammos S
    Cardiol Young; 2004 Aug; 14(4):367-72. PubMed ID: 15680041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter closure of fenestrations and excluded hepatic veins after fontan: versatility of the Amplatzer device.
    Moore JW; Murdison KA; Baffa GM; Kashow K; Murphy JD
    Am Heart J; 2000 Sep; 140(3):534-40. PubMed ID: 10966558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secundum ASD--not for closure.
    Goyal NK; Behera H; Kothari SS
    Indian Heart J; 2005; 57(3):268-9. PubMed ID: 16196189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk.
    Amin Z; Hijazi ZM; Bass JL; Cheatham JP; Hellenbrand WE; Kleinman CS
    Catheter Cardiovasc Interv; 2004 Dec; 63(4):496-502. PubMed ID: 15558755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder.
    Spies C; Strasheim R; Timmermanns I; Schraeder R
    Eur Heart J; 2006 Feb; 27(3):365-71. PubMed ID: 16254007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstruction of lateral tunnel fontan by an adjustable occluder device.
    Biniwale RM; Wells WJ; Herrington CS; Starnes VA
    J Card Surg; 2009; 24(6):750-2. PubMed ID: 20078723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aortic arch embolization of an Amplatzer occluder after an atrial septal defect closure: hybrid operative approach without circulatory arrest.
    Costache V; Chavanon O; Thony F; Blin D
    Eur J Cardiothorac Surg; 2005 Aug; 28(2):340-2. PubMed ID: 15939606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Percutaneous closure of three septal defects by two Amplatz occluders implanted during the same procedure].
    Abadir S; Aggoun Y; Elbaz M; Massabuau P; Carrié D; Fauvel JM; Puel J; Acar P
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):835-8. PubMed ID: 17067105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter closure of secundum atrial septal defect using the Amplatzer Septal Occluder: initial results of a single medical center in Taiwan.
    Lin MC; Fu YC; Jan SL; Lin WW; Chu KH; Ting CT; Chen YT; Chi CS
    Acta Paediatr Taiwan; 2005; 46(1):17-23. PubMed ID: 16302572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Good results after closure of a arterial septal defect during heart catheterisation instead of surgery].
    Helbing WA; Rijlaarsdam ME; Beekman RP; Blom NA; Ottenkamp J
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):367-73. PubMed ID: 11887624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of stents to maintain atrial defects and fontan fenestrations in congenital heart disease.
    Bar-Cohen Y; Perry SB; Keane JF; Lock JE
    J Interv Cardiol; 2005 Apr; 18(2):111-8. PubMed ID: 15882157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Amplatzer occlusion devices to occlude Fontan baffle leaks during fenestration closure procedures.
    Crowley DI; Donnelly JP
    Catheter Cardiovasc Interv; 2008 Feb; 71(2):244-9. PubMed ID: 18327842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a new low profile Occlutech PLD device for closure of Fontan fenestrations.
    De Wolf D; Dessy H; Haas N
    Catheter Cardiovasc Interv; 2016 May; 87(6):E243-7. PubMed ID: 26526601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New technique for device closure of large atrial septal defects.
    Dalvi BV; Pinto RJ; Gupta A
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):102-7. PubMed ID: 15619315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac magnetic resonance imaging of atrial septal defect for transcatheter closure.
    Durongpisitkul K; Tang NL; Soongswang J; Laohaprasitiporn D; Nana A; Kangkagate C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S658-66. PubMed ID: 12403244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenestration closure after Fontan surgery. Contributions of percutaneous interventionism.
    Santisteban M; Pan M; Romero M; Casares J; Gómez E; Suárez de Lezo J
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):909-11. PubMed ID: 24774002
    [No Abstract]   [Full Text] [Related]  

  • 39. Surgical atrial septal defect closure after interventional occluder placement.
    Modine T; Larrue B; Leroy O; Fayad G
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):736. PubMed ID: 18243005
    [No Abstract]   [Full Text] [Related]  

  • 40. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
    Braun M; Gliech V; Boscheri A; Schoen S; Gahn G; Reichmann H; Haass M; Schraeder R; Strasser RH
    Eur Heart J; 2004 Mar; 25(5):424-30. PubMed ID: 15033255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.